Skip to main content
Shanghai MicroPort MedBot (Group) Co., Ltd. logo

Shanghai MicroPort MedBot (Group) Co., Ltd. — Investor Relations & Filings

Ticker · 2252 ISIN · CNE100004QP1 HKEX Manufacturing
Open in API
Filings indexed 263 across all filing types
Latest filing 2026-05-14 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 2252

About Shanghai MicroPort MedBot (Group) Co., Ltd.

http://www.medbotsurgical.com

Shanghai MicroPort MedBot (Group) Co., Ltd. is dedicated to the research, development, and commercialization of intelligent surgical robotics, offering comprehensive solutions across the five major surgical areas. The company's portfolio includes systems for complex minimally invasive procedures, orthopedic joint replacement, and vascular intervention. Key products include the Toumai® laparoscopic surgical robot, designed for multi-departmental use (e.g., urology, general surgery); the Honghu® orthopedic robot, which enhances precision in joint replacement; and the R-One® vascular interventional robot, which utilizes remote control to reduce X-ray exposure for medical staff. MedBot focuses on advancing surgical precision, efficiency, and safety, aiming to provide high-quality, universally accessible robotic surgery solutions that reduce surgical risk and accelerate patient recovery.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE CONVENED AND HELD ON FRIDAY, 5 JUNE 2026
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a proxy form used by shareholders to appoint proxies and vote at the Company’s upcoming Annual General Meeting. It is part of the materials sent to shareholders to solicit their votes and provide meeting information, aligning with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-14 English
NOTICE OF ANNUAL GENERAL MEETING TO BE CONVENED AND HELD ON FRIDAY, 5 JUNE 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice convening the company’s Annual General Meeting, detailing resolutions to be voted on, proxy appointment procedures, meeting date/time/venue and voting entitlements. It is not the actual annual report, financial statements, or presentation materials, but rather a solicitation for shareholder votes. This matches the definition for a Proxy Solicitation & Information Statement (PSI).
2026-05-14 English
2025 ANNUAL REPORT; 2025 REPORT OF THE SUPERVISORY COMMITTEE; PROPOSED 2025 ANNUAL PROFIT DISTRIBUTION PLAN; PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE NEW SHARES; PROPOSED GRANTING OF GENERAL MAND
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a shareholder circular providing detailed information for the company’s 2025 Annual General Meeting, including the notice of meeting, proxy form instructions, resolutions to be voted on (annual report approval, profit distribution plan, share issuance and buyback mandates, auditor re-appointment, share scheme adoption, etc.), definitions and appendices. It is clearly a proxy solicitation and information statement rather than the reports themselves or a simple announcement. Therefore, it fits the Proxy Solicitation & Information Statement category.
2026-05-14 English
PROPOSED ADOPTION OF SHARE SCHEME
Share Issue/Capital Change Classification · 85% confidence The document is an announcement by the board proposing to adopt a new share scheme (involving grants of new shares and/or options) subject to shareholder approval and Listing Rule compliance. This is not the full scheme circular or proxy statement itself, but a public notice of a share issue/capital change for incentive purposes. It therefore falls under the “Share Issue/Capital Change” category (Code: SHA).
2026-05-14 English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report submitted to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Shanghai MicroPort MedBot (Group) Co., Ltd. It includes detailed tables on movements in authorized/registered share capital, issued shares, treasury shares, share options, and confirmations related to compliance with listing rules. The document is structured as a regulatory return on share capital and share movements, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a regulatory filing itself. The document is specific to share capital movements and public float sufficiency confirmations under HKEX rules, which aligns with the category of Regulatory Filings (RNS) as a general regulatory announcement and compliance document that does not fit other specific categories like capital changes (SHA) or director dealings (DIRS). Therefore, the best classification is Regulatory Filings (RNS).
2026-05-06 English
2025 Annual Report
Regulatory Filings
2026-04-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.